Zyprexa

Lilly incurred the tax on $8 billion in overseas profits returned to the U.S.

Revenue rose to $3.88 billion from $3.64 billion.

Sales of Cymbalta, approved for U.S.

sale in August 2004, more than tripled.

The product is helping Chief Executive Officer Sidney Taurel to compensate for slowing sales of Lilly, which introduced the now-generic Prozac antidepressant in 1986, needs to rebuild its franchise in such central nervous system treatments, said JPMorgan Securities analyst Chris Shibutani in New York.

``Cymbalta has to be successful,'' said Shibutani, who doesn't own the stock, in an interview last week.

``Its importance lies in the expectation that it has blockbuster potential, and it is the most important of the company's new products.'' New drugs including Cymbalta will account for 24 percent of 2006 sales after a projected 18 percent in 2005 and 11 percent the year before, the company said in December.

Beats Expectations Excluding restructuring costs, Lilly said fourth-quarter profit was 80 cents a share, beating the 78 cents estimated b...

Read more...